bioRxivBiophysics
Oxidation shuts down an auto-inhibitory mechanism of von Willebrand factor
Abstract
The blood protein von Willebrand factor (VWF) is a key link between inflammation and pathological thrombus formation. In particular, oxidation of methionine residues in specific domains of VWF due to the release of oxidants in inflammatory conditions has been linked to an increased platelet-binding activity. However, the atomistic details how methionine oxidation activates VWF have not been elucidated to date. Yet understanding the activation mechanism of VWF under oxidizing conditions can lead to the development of novel therapeutics that target VWF selectively under inflammatory conditions in order to reduce its thrombotic activity while maintaining its haemostatic function. In this manuscript, we used a combination of a dynamic flow assay and molecular dynamics (MD) simulations to investigate how methionine oxidation removes an auto-inhibitory mechanism of VWF. Results from the dynamic flow assay revealed that oxidation does not directly activate the A1 domain, which is the domain in VWF that contains the binding site to the platelet surface receptor glycoprotein Ib (GpIb), but rather removes the inhibitory function of the neighboring A2 and A3 domains. Furthermore, the MD simulations combined with free energy perturbation calculations suggested that methionine oxidation may destabilize the binding interface between the A1 and A2 domains leading to unmasking of the GpIb-binding site in the A1 domain.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: mechanistic / dynamical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Exploring ligands that target von Willebrand factor selectively under oxidizing conditions through docking and molecular dynamics simulations
G. Interlandi·bioRxiv·Mar 22, 2024
- Targeting von Willebrand factor selectively under inflammatory conditions
Gianluca Interlandi, Victoria S. Carter, … Xiaoyun Fu·bioRxiv·Aug 13, 2025
- Distinct platelet interactions with soluble and immobilized von Willebrand factor modulate platelet adhesion and aggregation with differential impact on hemostasis and thrombosis
Y. Chen, Z. M. Ruggeri·bioRxiv·Jan 31, 2024
- Flow molecular dynamics simulations reveal mechanosensitive regulation of von Willebrand factor through glycan-modulated autoinhibitory modules
Naveen Eugene Louis, Yunduo Charles Zhao, Lining Arnold Ju·bioRxiv·Apr 7, 2026
- Thermodynamic stabilization of the von Willebrand Factor A1 domain due to loss-of-function disease-related mutations.
A. Sandoval-Perez, V. Mejia-Restrepo, C. Aponte-Santamaria·bioRxiv·Mar 10, 2022
- Dynamic Disulfide Bond Topologies in von-Willebrand-Factor's C4-Domain Undermine Platelet Binding
F. Kutzki, D. Butera, … F. Graeter·bioRxiv·Aug 20, 2022